Genomic spectra of biliary tract cancer-Reference-Cited by-同舟云学术

Genomic spectra of biliary tract cancer

Published:2015-08-10 Issue:9 Volume:47 Page:1003-1010
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Nakamura Hiromi,Arai Yasuhito,Totoki Yasushi,Shirota Tomoki,Elzawahry Asmaa,Kato Mamoru,Hama Natsuko,Hosoda Fumie,Urushidate Tomoko,Ohashi Shoko,Hiraoka Nobuyoshi,Ojima Hidenori,Shimada Kazuaki,Okusaka Takuji,Kosuge Tomoo,Miyagawa Shinichi,Shibata Tatsuhiro

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3375.pdf

Reference42 articles.

1. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011).

2. Patel, T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2, 10 (2002).

3. Tyson, G.L. & El-Serag, H.B. Risk factors for cholangiocarcinoma. Hepatology 54, 173–184 (2011).

4. Rizvi, S. & Gores, G.J. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145, 1215–1229 (2013).

5. Razumilava, N. & Gores, G.J. Cholangiocarcinoma. Lancet 383, 2168–2179 (2014).

Cited by 962 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. HNF6 and HNF4α expression in adenocarcinomas of the liver, pancreaticobiliary tract, and gastrointestinal tract: an immunohistochemical study of 480 adenocarcinomas of the digestive system;Pathology;2024-10

3. What eliminates the chance for cure: a multi-center evaluation on 10-year follow-up of gallbladder cancer after surgical resection;Annals of Medicine;2024-09-12

4. Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models;Journal of Cellular and Molecular Medicine;2024-09

5. Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma;Genomics;2024-09